The SIGNIFY trial is testing the hypothesis that treatment with ivabradine reduces mortality and cardiovascular events in patients with stable coronary artery disease (CAD), without clinical heart failure.
http://www.signify-trial.org/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
2.3 seconds
BIOFARMA
Domain Manager
50 r●●●●rnot
SUR●●●NES , cedex, 92284
FR
View this contact
BIOFARMA
Domain Manager
50 r●●●●rnot
SUR●●●NES , cedex, 92284
FR
View this contact
MarkMonitor
Domain Admin
PM●●55
Bo●●se , ID, 83709-1433
US
View this contact
BUY YOUR DOMAIN
MarkMonitor Inc. (R37-LROR)
WHOIS : whois.publicinterestregistry.net
REFERRED :
PAGES IN
THIS WEBSITE
1
SSL
EXTERNAL LINKS
0
SITE IP
92.103.89.165
LOAD TIME
2.297 sec
SCORE
6.2
SIGNIFY: the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease | signify-trial.org Reviews
https://signify-trial.org
The SIGNIFY trial is testing the hypothesis that treatment with ivabradine reduces mortality and cardiovascular events in patients with stable coronary artery disease (CAD), without clinical heart failure.
signify-trial.org
Prof Kim Fox (Chair) - SIGNIFY
http://www.signify-trial.org/committees-and-investigators/executive-committee/prof-kim-fox-chair
Results in the subgroup of patients with angina. Prof Kim Fox (Chair). Prof Roberto Ferrari (Co-Chair). Prof Philippe Gabriel Steg. Raquo; Committees and Investigators. Raquo; Executive Committee. Raquo; Prof Kim Fox (Chair). Prof Kim Fox (Chair). National Heart and Lung Institute. Professor Fox has published 400 papers in leading scientific journals. His expertise is in the understanding, investigation, and treatment of angina, and he has played a major role in international clinical trials (TIBET, ...
TOTAL PAGES IN THIS WEBSITE
1
SIGNIFY: the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease
Results in the subgroup of patients with angina. Prof Kim Fox (Chair). Prof Roberto Ferrari (Co-Chair). Prof Philippe Gabriel Steg. What is the SIGNIFY trial? The SIGNIFY trial is testing the hypothesis that treatment with ivabradine*, from 7.5 mg bid to 10 mg bid, reduces mortality and cardiovascular events in patients with stable coronary artery disease (CAD), without clinical heart failure. 19 102 stable CAD patients – 51 countries – 1 139 centers. Download the SIGNIFY results slide set.
SIGNIFY: the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease
Results in the subgroup of patients with angina. Prof Kim Fox (Chair). Prof Roberto Ferrari (Co-Chair). Prof Philippe Gabriel Steg. What is the SIGNIFY trial? The SIGNIFY trial is testing the hypothesis that treatment with ivabradine*, from 7.5 mg bid to 10 mg bid, reduces mortality and cardiovascular events in patients with stable coronary artery disease (CAD), without clinical heart failure. 19 102 stable CAD patients – 51 countries – 1 139 centers. Download the SIGNIFY results slide set.
SIGNIFY: the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease
Results in the subgroup of patients with angina. Prof Kim Fox (Chair). Prof Roberto Ferrari (Co-Chair). Prof Philippe Gabriel Steg. What is the SIGNIFY trial? The SIGNIFY trial is testing the hypothesis that treatment with ivabradine*, from 7.5 mg bid to 10 mg bid, reduces mortality and cardiovascular events in patients with stable coronary artery disease (CAD), without clinical heart failure. 19 102 stable CAD patients – 51 countries – 1 139 centers. Download the SIGNIFY results slide set.
SIGNIFY: the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease
Results in the subgroup of patients with angina. Prof Kim Fox (Chair). Prof Roberto Ferrari (Co-Chair). Prof Philippe Gabriel Steg. What is the SIGNIFY trial? The SIGNIFY trial is testing the hypothesis that treatment with ivabradine*, from 7.5 mg bid to 10 mg bid, reduces mortality and cardiovascular events in patients with stable coronary artery disease (CAD), without clinical heart failure. 19 102 stable CAD patients – 51 countries – 1 139 centers. Download the SIGNIFY results slide set.
SIGNIFY: the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease
Results in the subgroup of patients with angina. Prof Kim Fox (Chair). Prof Roberto Ferrari (Co-Chair). Prof Philippe Gabriel Steg. What is the SIGNIFY trial? The SIGNIFY trial is testing the hypothesis that treatment with ivabradine*, from 7.5 mg bid to 10 mg bid, reduces mortality and cardiovascular events in patients with stable coronary artery disease (CAD), without clinical heart failure. 19 102 stable CAD patients – 51 countries – 1 139 centers. Download the SIGNIFY results slide set.
SIGNIFY: the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease
Results in the subgroup of patients with angina. Prof Kim Fox (Chair). Prof Roberto Ferrari (Co-Chair). Prof Philippe Gabriel Steg. What is the SIGNIFY trial? The SIGNIFY trial is testing the hypothesis that treatment with ivabradine*, from 7.5 mg bid to 10 mg bid, reduces mortality and cardiovascular events in patients with stable coronary artery disease (CAD), without clinical heart failure. 19 102 stable CAD patients – 51 countries – 1 139 centers. Download the SIGNIFY results slide set.
Signify.at
Default Parallels Plesk Panel Page
Web Server's Default Page. This page is generated by Parallels Plesk Panel. The leading hosting automation software. You see this page because there is no Web site at this address. You can do the following:. Create domains and set up Web hosting using Parallels Plesk Panel. Parallels is a worldwide leader in virtualization and automation software that optimizes computing for consumers, businesses, and Cloud services providers across all major hardware, operating systems, and virtualization platforms.
Trigon Construction
News, Events and Publications. Trigon Construction Management is a privately owned firm operating in Southern Ontario since 1997. We provide General Contracting, Design-Build, Construction Management, and Consulting Services to a variety of clients. We are a team committed to one vision Clarity in Construction. Trigon Construction Management is built on three fundamental approaches to transparent business practices; Relationships, Communication & Adaptability. Click to view brochure….
Signify – a Smarter Web Company » Signify
Proud to support the Poppy Places Trust. Signify is proud to be able to support the PoppyPlaces. Trust with a great WW100 project. Lest we forget. Launching Tappy, your next game fix is here! Just launched, Tappy our quick fire "Smash-em Danno" block game available on both IOS and Android platforms. Innovative Mobile and Web Development. Signify offer websites, intranets, responsive development, mobile development. New Zealand Petroleum and Minerals website. Trade Me Annual Report 2014. Kia Ora, hello!
